PA
GNW icon

PharVision Advisers’s Genworth Financial GNW Stock Holding History

PharVision Advisers’s Portfolio GNW Stock Details GNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,050
Closed -$116K – 810
2025
Q3 		$116K Sell
13,050
-26,450
-67% -$218K 0.07% 610
2025
Q2 		$307K Buy
+39,500
New +$276K 0.44% 77

Other funds holding GNW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's GNW Position: Q4 2025 in Review

PharVision Advisers sold out of Genworth Financial (GNW) in Q4 2025, closing a stake of 13,050 shares — an estimated $116K sold.

PharVision Advisers first reported a position in GNW in Q2 2025 and held it in 2 quarters. The position peaked at $307K in Q2 2025. 365 funds tracked by Wall St. Rank hold GNW as of Q4 2025.

  • PharVision Advisers reported no remaining Genworth Financial position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 13,050 Genworth Financial shares in Q4 2025, an estimated $116K.
  • PharVision Advisers first reported a position in Genworth Financial in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's Genworth Financial position peaked at $307K in Q2 2025.
  • 365 funds tracked by Wall St. Rank held Genworth Financial as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.